Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

immunity · Mechanism Report

Does prior Lyme disease reliably protect against reinfection?

Prior treated Lyme disease does not reliably protect against future Lyme infection.

PlausibleOctober 13, 20268 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Prior Lyme disease does not provide reliable protection from reinfection, so repeated tick bites in an endemic wooded setting can create new exposure opportunities.

laying out figure…
3 of 5 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says that a past Lyme infection should not be assumed to prevent a new one. The mechanism framing emphasizes incomplete, largely strain-specific immunity and the fact that repeated exposure to infected ticks in endemic wooded settings can create new infection opportunities.

Verified conclusion

Prior treated Lyme disease does not provide dependable protection against a future infection. For a 71-year-old living or spending time in endemic wooded areas, a new attached Ixodes tick can represent a new exposure even after prior Lyme disease.

Clinical evidence

  • Culture-confirmed recurrent erythema migrans directly supports reinfection: among 17 patients with 22 paired episodes, every recurrent episode involved a genotypically distinct Borrelia burgdorferi strain. A new typical erythema migrans rash after renewed tick exposure should therefore be considered a new episode rather than assumed relapse.
  • Repeated tick encounters increase exposure opportunity, though not every bite causes infection. In prospective household data, reported tick encounters were associated with verified tick-borne disease (risk ratio 2.60), although the endpoint was not Lyme disease alone.

Environmental risk and transmission

  • Wooded and woodland–residential interface settings materially raise infected-tick hazard. A 2024 study found nymphal tick density fourfold higher at interfaces and 15-fold higher in woodland than residential areas; infection prevalence was 15–24 times higher outside residential habitats.
  • In Nassau County surveillance, 50.44% of tested I. scapularis carried B. burgdorferi. Transmission still requires an infected tick and adequate attachment; risk generally becomes substantial after approximately 36–48 hours, and prompt removal reduces risk.

Mechanistic context and practical implications

  • Immunity after Lyme disease appears incomplete and largely strain-specific: protection against certain prior strain types persisted at least four years, while reinfecting strains were usually genetically distinct. Antigenic variation, including VlsE-mediated immune escape, provides a biologically plausible basis for limited cross-strain protection.
  • For a clearly high-risk bite—identified Ixodes, highly endemic area, and attachment ≥36 hours—single-dose doxycycline within 72 hours of removal is recommended; otherwise observation is preferred.

Bottom line

  • Prior Lyme disease may provide partial strain-limited immunity, but it is not reliable protection. Recurrent bites in endemic wooded settings create genuine new opportunities for Lyme disease, making bite prevention, prompt tick removal, and assessment of new erythema migrans especially important.

References

  1. Differentiation of Reinfection from Relapse in Recurrent Lyme Disease | NEJM — nejm.org ↗
  2. Evidence for Strain-Specific Immunity in Patients Treated ... — pmc.ncbi.nlm.nih.gov ↗
  3. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease — acrjournals.onlinelibrary.wiley.com ↗
  4. Active surveillance of pathogens from ticks collected in New ... — pmc.ncbi.nlm.nih.gov ↗
  5. AAN/ACR/IDSA 2020 Guidelines for the Prevention, Diagnosis and ... — idsociety.org ↗
  6. Human-tick encounters as a measure of tickborne disease risk in lyme disease endemic areas — stacks.cdc.gov ↗
  7. Ixodes scapularis density and Borrelia burgdorferi prevalence ... — pmc.ncbi.nlm.nih.gov ↗
  8. Ixodes scapularis density and Borrelia burgdorferi prevalence along a residential-woodland gradient in a region of emerging Lyme disease risk - Scientific Reports — nature.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible10 sourcesDoes pathogen-specific IgM reflect recent immune recognition while a negative blood PCR still miss prior or tissue-limited infection?→Unsupported7 sourcesDoes IgG/IgA reactivity prove ongoing cancer?→